Exane Derivatives’s Ventas VTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3
Closed -$185 997
2022
Q1
$185 Buy
+3
New +$164 ﹤0.01% 967
2021
Q4
Sell
-55
Closed -$3.04K 1045
2021
Q3
$3.04K Hold
55
﹤0.01% 770
2021
Q2
$3.24K Hold
55
﹤0.01% 794
2021
Q1
$2.93K Hold
55
﹤0.01% 655
2020
Q4
$2.7K Sell
55
-117
-68% -$5.41K ﹤0.01% 600
2020
Q3
$7.22K Hold
172
﹤0.01% 482
2020
Q2
$6.3K Sell
172
-74
-30% -$2.44K ﹤0.01% 434
2020
Q1
$6.59K Hold
246
﹤0.01% 441
2019
Q4
$14.2K Sell
246
-265
-52% -$16.6K ﹤0.01% 405
2019
Q3
$37.3K Hold
511
0.01% 380
2019
Q2
$34.9K Sell
511
-43
-8% -$2.74K 0.01% 407
2019
Q1
$35.3K Buy
554
+85
+18% +$5.31K 0.01% 357
2018
Q4
$27.5K Hold
469
﹤0.01% 421
2018
Q3
$25.1K Buy
469
+48
+11% +$2.78K ﹤0.01% 406
2018
Q2
$24.1K Buy
421
+36
+9% +$1.88K ﹤0.01% 424
2018
Q1
$19.4K Sell
385
-84
-18% -$4.41K ﹤0.01% 394
2017
Q4
$28.1K Sell
469
-98
-17% -$6.19K ﹤0.01% 374
2017
Q3
$36.9K Sell
567
-23
-4% -$1.55K 0.01% 328
2017
Q2
$41K Buy
590
+1
+0.2% +$67 0.01% 330
2017
Q1
$38.3K Buy
589
+73
+14% +$4.55K 0.01% 282
2016
Q4
$32.3K Buy
516
+28
+6% +$1.77K 0.01% 328
2016
Q3
$34.5K Buy
488
+34
+7% +$2.47K 0.01% 329
2016
Q2
$33.1K Sell
454
-267
-37% -$17.6K 0.01% 302
2016
Q1
$45.4K Hold
721
0.01% 328
2015
Q4
$40.7K Buy
721
+175
+32% +$9.52K 0.01% 267
2015
Q3
$30.6K Buy
546
+50
+10% +$3.28K ﹤0.01% 300
2015
Q2
$35.1K Hold
496
﹤0.01% 308
2015
Q1
$41.3K Buy
496
+144
+41% +$12.4K ﹤0.01% 329
2014
Q4
$28.8K Buy
+352
New +$27.8K ﹤0.01% 357

Other funds holding VTR

Exane Derivatives's VTR Position: Q2 2022 in Review

Exane Derivatives sold out of Ventas (VTR) in Q2 2022, closing a stake of 3 shares — an estimated $185 sold.

Exane Derivatives first reported a position in VTR in Q4 2014 and held it in 29 quarters. The position peaked at $45.4K in Q1 2016. 646 funds tracked by Wall St. Rank hold VTR as of Q2 2022.

  • Exane Derivatives reported no remaining Ventas position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 3 Ventas shares in Q2 2022, an estimated $185.
  • Exane Derivatives first reported a position in Ventas in Q4 2014 and held it in 29 quarters.
  • Exane Derivatives's Ventas position peaked at $45.4K in Q1 2016.
  • 646 funds tracked by Wall St. Rank held Ventas as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.